About the Journal

Instructions to Authors

Available at https://revistas.usp.br/bjps/InstructionstoAuthors.

Journal History

The Brazilian Journal of Pharmaceutical Sciences has its origin in 1939 with the publication of the "Anais de Farmácia e Odontologia da USP". In 1963, the Journal name changed to "Revista da Faculdade de Farmácia e Bioquímica da Universidade de São Paulo" and in 1970 the Journal was renamed again as "Revista de Farmácia e Bioquímica da Universidade de São Paulo".

In 1999, the Journal was totally remodeled and renamed Revista Brasileira de Ciências Farmacêuticas/Brazilian Journal of Pharmaceutical Sciences. From 2009 on, celebrating 70 years of publishing, a new era started. The Journal adopted exclusively the English denomination and at present accepts only papers in English. In addition, in 2019 it moved to a continuous publishing model.

All these changes aimed at increasing the national and international visibility of the Brazilian Journal of Pharmaceutical Sciences and speeding the process of publication towards consolidating it as one of the main journals in Pharmaceutical Sciences.

The abbreviation is Braz. J. Pharm. Sci., which should be used in bibliographies, footnotes and bibliographical references and strips.

SCOPE AND POLICY

The Brazilian Journal of Pharmaceutical Sciences publishes manuscripts that significantly contribute to knowledge in all areas of Pharmaceutical Sciences, including:

  •  Medicinal Chemistry, Drug Discovery and Development, Pharmacognosy;
  •  Pharmaceutical Technology, Drug Delivery;
  •  Clinical Pharmacy and Pharmacokinetics, Pharmaceutical Care, Pharmaceutical Services;
  •  Clinical-Bioanalytical Chemistry and Pharmaceutical Analysis;
  •  Food Science and Nutrition, focusing on Nutrigenomics, Immunonutrition, Functional foods and supplements, Food bioactive compounds, and Food and drug interactions;
  •  Vaccines and Biologicals;
  •  Cosmetology;
  •  Toxicology

Editorial Process

All manuscripts undergo an initial evaluation to check for the presence of all required attachments as well as the correct text format. If the authors fail to follow all submission instructions more than twice, the manuscript will be preliminarily rejected.  

If the manuscript meets these initial criteria, it is then reviewed by the Editor-in-Chief to assess the quality of the content and alignment with the Journal’s scope and basic policies. Following this, the manuscript is addressed to an appropriate Associate Editor and, if considered adequate, subjected to a single-blind peer review process. Based on the feedback from this review, the Editor-in-Chief decides whether the manuscript should be accepted, revised (requiring major or minor revisions), or rejected.

Peer Review Process

Manuscripts submitted to the Brazilian Journal of Pharmaceutical Sciences must conform to the journal's scope, undergo an initial plagiarism check by the author, and be accompanied by a plagiarism report certificate. Submissions are evaluated and, if compliant, reviewed by at least two anonymous reviewers that will evaluate the manuscript regarding novelty, scientific importance, organization, clarity, conciseness, analytical and critical skills, and adequate references. Based on these opinions, the Associate Editor makes a preliminary recommendation and the Editor-in-Chief makes the final decision on the manuscript, which can be accepted, rejected, or returned for revisions. This decision is communicated to the authors and, if revisions are needed, they must submit a revised manuscript within 60 days. The authors must justify to the Editor in case additional time is needed to prepare the revised version. The revised text must be typed in black, highlighted in yellow and be accompanied by a rebuttal letter discussing each point raised by the reviewers in a point-by-point manner. The rebuttal letter should also indicate the page and line number where each revision has been made. Revised manuscripts are reassessed, and the final decision on acceptance, rejection, or further revisions is based on this review and the editors' assessment. In line with open science principles, starting in 2024, accepted articles will be published along with the name of the editor responsible for handling and accepting the study.  

Open Data

In line with the principles of Open Science, the Brazilian Journal of Pharmaceutical Sciences encourages the sharing of data, codes, methods, and other materials used in and resulting from the research published in the Journal in the SciELO Data repository. This includes all forms of data that support the research findings, such as raw and processed data, audio and video files, code, software, algorithms, protocols, and methods. This practice is encouraged to facilitate data verification and reuse, thereby increasing the credibility and impact of the research published.

Preprints

The Brazilian Journal of Pharmaceutical Sciences recognizes the importance of new scientific mediums and enables readers and researchers to have faster access to recent research findings prior to its publication. Therefore, the journal welcomes manuscripts that have been deposited on non-commercial preprint servers.

A preprint is a preliminary version of a scientific work that is publicly shared in online repositories before undergoing peer review and eventual publication in a scientific journal. It is a way to accelerate the process of scientific communication, enabling researchers to promptly share their findings with the academic community. Preprints can be found in public repositories such as SciELO Preprints. These repositories, maintained by non-profit organizations, provide free access to the public for reading and downloading purposes.

To ensure transparency and integrity in handling preprints submitted to the Brazilian Journal of Pharmaceutical Sciences, authors must provide the following information:

  • Preprint Identification: Title, authors, repository where it was published, publication date and DOI.
  • Conflicts of Interest: Authors should disclose any conflicts of interest related to the preprint, such as funding from a company or institution with an interest in the work.

Fees

There are no charges for articles submission, evaluation, and publication.

Sponsors

The Journal receives financial support from: Programa de Apoio às Publicações Científicas Periódicas da USP and the School of Pharmaceutical Sciences, University of São Paulo (USP).

Indexing sources

The Journal is indexed and recognized by several prestigious databases and systems, which underscores its credibility and reach within the scientific community. Here is a summary of the indexing and classification details:

Sources of Support